Generic Drug Cos. Face Failure-To-Warn Claims In Calif.
On Jan. 20, 2015, the U.S. Supreme Court declined to hear an appeal involving failure-to-warn claims against generic pharmaceutical manufacturers. Teva Pharms. USA Inc. v. Super. Ct., No. 13-956 (U.S. Jan....To view the full article, register now.
Already a subscriber? Click here to view full article